148 related articles for article (PubMed ID: 26510692)
1. Implication of thymoquinone as a remedy for polycystic ovary in rat.
Arif M; Thakur SC; Datta K
Pharm Biol; 2016; 54(4):674-85. PubMed ID: 26510692
[TBL] [Abstract][Full Text] [Related]
2. Disrupted hyaluronan binding protein 1 (HABP1) expression: one of the key mediator for ovarian dysfunction in polycystic ovary rat.
Arif M; Thakur SC; Datta K
Mol Cell Biochem; 2015 Jan; 398(1-2):233-44. PubMed ID: 25300617
[TBL] [Abstract][Full Text] [Related]
3. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.
Sethi G; Ahn KS; Aggarwal BB
Mol Cancer Res; 2008 Jun; 6(6):1059-70. PubMed ID: 18567808
[TBL] [Abstract][Full Text] [Related]
4. Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment.
Saha P; Kumar S; Datta K; Tyagi RK
J Steroid Biochem Mol Biol; 2021 Apr; 208():105823. PubMed ID: 33484844
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.
El Gazzar MA; El Mezayen R; Nicolls MR; Dreskin SC
Biochim Biophys Acta; 2007 Apr; 1770(4):556-64. PubMed ID: 17292554
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Khabele D; Yull F
Mol Cancer; 2015 Nov; 14():192. PubMed ID: 26552746
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis.
Vaillancourt F; Silva P; Shi Q; Fahmi H; Fernandes JC; Benderdour M
J Cell Biochem; 2011 Jan; 112(1):107-17. PubMed ID: 20872780
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo.
Finlay TM; Abdulkhalek S; Gilmour A; Guzzo C; Jayanth P; Amith SR; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Aug; 27(6):583-600. PubMed ID: 20697956
[TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic effect of thymoquinone on hepatic stellate cells.
Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S
Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo.
Kundu JK; Liu L; Shin JW; Surh YJ
Biochem Biophys Res Commun; 2013 Sep; 438(4):721-7. PubMed ID: 23911786
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a model of Status Epilepticus.
Shao Y; Feng Y; Xie Y; Luo Q; Chen L; Li B; Chen Y
Neurochem Res; 2016 Dec; 41(12):3399-3406. PubMed ID: 27752802
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary.
Rezvanfar MA; Saeedi S; Mansoori P; Saadat S; Goosheh M; Shojaei Saadi HA; Baeeri M; Abdollahi M
Pharm Biol; 2016; 54(1):80-90. PubMed ID: 25955958
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of thymoquinone and its protective effects against several diseases.
Kohandel Z; Farkhondeh T; Aschner M; Samarghandian S
Biomed Pharmacother; 2021 Jun; 138():111492. PubMed ID: 33743334
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats.
El-Khouly D; El-Bakly WM; Awad AS; El-Mesallamy HO; El-Demerdash E
Toxicology; 2012 Dec; 302(2-3):106-13. PubMed ID: 22982510
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone reduces intracytoplasmic oxidative stress and improves epigenetic modification in polycystic ovary syndrome mice oocytes, during in-vitro maturation.
Eini F; Bidadkosh A; Nazarian H; Piryaei A; Ghaffari Novin M; Joharchi K
Mol Reprod Dev; 2019 Aug; 86(8):1053-1066. PubMed ID: 31209968
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone inhibits matrix metalloproteinase expression in rabbit chondrocytes and cartilage in experimental osteoarthritis.
Chen WP; Tang JL; Bao JP; Wu LD
Exp Biol Med (Maywood); 2010 Dec; 235(12):1425-31. PubMed ID: 21127340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
